Ridgeback Capital Investments

Latest statistics and disclosures from Ridgeback Capital Investments's latest quarterly 13F-HR filing:

Ridgeback Capital Investments portfolio companies for September 2012 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
MDCO Medicines Company 15.78 NEW 1050400 25.81 24.55
IRWD Ironwood Pharmaceuticals 15.57 -11.00% 2093307 12.78 10.45
ARIA Ariad Pharmaceuticals 14.09 +17.00% 1000000 24.21 7.20
CLDX Celldex Therapeutics 10.49 +18.00% 2860525 6.30 14.24
GILD Gilead Sciences 9.65 NEW 250000 66.33 70.00
SNTS Santarus 8.44 -15.00% 1633514 8.88 31.96
ARRY Array BioPharma 6.50 1910898 5.84 3.79
Sunesis Pharmaceuticals 5.36 +13.00% 1634887 5.63 0.00
Clovis Oncology 4.12 NEW 345954 20.45 0.00
ONXX Onyx Pharmaceuticals 3.90 +9.00% 79265 84.50 124.70
REGN Regeneron Pharmaceuticals 1.79 -42.00% 20100 152.64 296.74
SGMO Sangamo Biosciences 1.33 376359 6.08 13.99
DVAX Dynavax Technologies Corporation 0.98 -29.00% 352700 4.76 1.50
Hyperion Therapeutics 0.71 NEW 115000 10.63 0.00
XNPT XenoPort 0.63 +311.00% 95000 11.45 4.20
Biolinerx Ltd-spons 0.29 +99.00% 189511 2.63 0.00
DUSA DUSA Pharmaceuticals 0.23 +232.00% 57200 6.78 0.00
LXRX Lexicon Pharmaceuticals 0.14 100000 2.32 1.63